Lanxess (ETR:LXS) has been assigned a €55.00 ($63.95) target price by JPMorgan Chase & Co. in a research note issued on Thursday. The brokerage presently has a “buy” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 20.38% from the stock’s previous close.
Other analysts have also issued research reports about the company. Citigroup set a €80.00 ($93.02) target price on Lanxess and gave the stock a “buy” rating in a research note on Friday, September 21st. Goldman Sachs Group set a €86.00 ($100.00) target price on Lanxess and gave the stock a “buy” rating in a research note on Thursday, September 20th. Kepler Capital Markets set a €86.00 ($100.00) target price on Lanxess and gave the stock a “buy” rating in a research note on Wednesday, September 19th. Finally, UBS Group set a €78.00 ($90.70) target price on Lanxess and gave the stock a “buy” rating in a research note on Monday, September 24th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and nine have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of €64.25 ($74.71).
Shares of LXS opened at €45.69 ($53.13) on Thursday. Lanxess has a 1 year low of €59.89 ($69.64) and a 1 year high of €74.50 ($86.63).
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
Featured Story: When is a capital gain realized?
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.